Percentage of Patients With A1C ≤6.5% at 40 Weeks<sup>1,3*</sup>

Accordion title open

Show Description

Accordion title close

Close Description

Graph showing the percentage of patients who had an A1C of less than or equal to 6.5% 40 weeks

Percentage of Patients With A1C ≤6.5% at 40 Weeks^1,3*

Bar graph showing the percentage of adult patients with type 2 diabetes on metformin in the SURPASS-2 study who had an A1C of less than or equal to 6.5% at 40 weeks. Graph shows Mounjaro vs Ozempic 1 mg. The bar graph shows the percentage of adult patients with type 2 diabetes on metformin in the SURPASS-2 study who had an A1C of less than 6.5% at 40 weeks. From a mean baseline A1C of 8.3%, 69% (Mounjaro 5 mg, n=470), 77% (Mounjaro 10 mg, n=469), 80% (Mounjaro 15 mg, n=469), and 64% (Ozempic 1 mg, n=468) of patients had an A1C of less than or equal to 6.5%.

Percentage of Patients With A1C ≤6.5% at 40 Weeks1,3*

Percentage of Patients With A1C ≤6.5% at 40 Weeks^1,3*